<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>Conference and Labs of the Evaluation Forum, September</journal-title>
      </journal-title-group>
    </journal-meta>
    <article-meta>
      <title-group>
        <article-title>ALSFRS-R Score Prediction for Amyotrophic Lateral Sclerosis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <string-name>Guido Barducci</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Flavio Sartori</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Giovanni Birolo</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Tiziana Sanavia</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Piero Fariselli</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <aff id="aff0">
          <label>0</label>
          <institution>Computational Biomedicine Unit, Dept. of Medical Sciences, University of Turin</institution>
          ,
          <addr-line>Turin</addr-line>
          ,
          <country country="IT">Italy</country>
        </aff>
      </contrib-group>
      <pub-date>
        <year>2024</year>
      </pub-date>
      <volume>0</volume>
      <fpage>9</fpage>
      <lpage>12</lpage>
      <abstract>
        <p>Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that results in the gradual deterioration of motor abilities, leading to challenges in breathing, speaking, swallowing, and ultimately death, typically occurring within a few years. The symptoms of ALS can vary significantly from one individual to another, afecting various bodily functions and areas. To assess this wide range of symptoms, the Amyotrophic Lateral Sclerosis Functional Rating Scale - Revised (ALSFRS-R) is utilized. Predicting the ALSFRS-R score is clinically relevant for personalizing patient monitoring. To address this need, the Intelligent Disease Progression Prediction challenge was organized, tasking participants with developing novel methods to predict these scores using non-invasive sensor data that monitor some individual characteristics. The competition included two tasks that difered only in the way the ALSFRS-R questionnaires were completed: either by medical staf (task 1) or by the patient (task 2). Given the limited number of patients on the training set, it was decided to use a relatively simple model, Random Forest, and to preselect sensor features by retaining those most correlated with the outcome to be predicted. We selected the model with the lowest MAE estimated by cross-validation on the challenge training set. The competition results demonstrate that our method attained on the test set an average Mean Absolute Error (MAE) of 0.234 and 0.311, along with a Root Mean Square Error (RMSE) of 0.519 and 0.601 for tasks 1 and 2, respectively. Although the error may appear very low, this is because questionnaire values tend to remain constant from one visit to another, thus facilitating prediction.</p>
      </abstract>
      <kwd-group>
        <kwd>eol&gt;Machine Learning</kwd>
        <kwd>ALS</kwd>
        <kwd>ALSFRS-R</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec-1">
      <title>1. Introduction</title>
      <p>
        of this paper is to utilize information collected through the sensors of a commercial fitness smartwatch,
past ALSFRS-R scores, and static features (such as age, sex, etc.) to predict future ALSFRS-R scores. The
questionnaire data available has two diferent sources: they can be filled out by a doctor or by the patient
through the use of a dedicated smartphone application. Therefore, the challenge has been divided into
two tasks with the same goal but using data from diferent sources characterized by diferent frequencies
of intervals between one questionnaire and the next, as well as difering medical or personal opinions,
which may lead to diferent scoring choices despite similar symptoms. To solve these tasks, classical
machine learning models were used instead of deep learning given the small number of patients in the
training dataset. For more details we refer the reader to the challenge overview papers [
        <xref ref-type="bibr" rid="ref4 ref5">4, 5</xref>
        ].
      </p>
      <p>The paper is divided into the following sections: 2 Related Work, which reports some papers
addressing topics similar to this work; 3 Methodology, where the entire procedure that led to the predictions
for the two tasks is outlined; 4 Experimental Setup, which details the procedures used; 5 Results, where
the obtained results along with performance metrics are presented; and 6 Conclusions and Future Work,
which reviews the essential steps of the paper and proposes alternative methodologies that could be
useful for improving predictions.</p>
    </sec>
    <sec id="sec-2">
      <title>2. Related Work</title>
      <p>
        The quest to identify prognostic factors and build predictive models for amyotrophic lateral sclerosis
(ALS) progression has been a longstanding challenge, but one of paramount importance. ALS exhibits
significant variability in its progression and outcomes, posing obstacles to making accurate predictions.
Many methodologies have undergone rigorous testing using data from the PRO-ACT database. While
this repository may not perfectly capture the full spectrum of ALS patients in the population, it stands
as the largest publicly accessible dataset amalgamating ALS clinical trials [
        <xref ref-type="bibr" rid="ref6">6</xref>
        ] [
        <xref ref-type="bibr" rid="ref7">7</xref>
        ] [
        <xref ref-type="bibr" rid="ref8">8</xref>
        ].
      </p>
      <p>
        Wearable devices have been efectively used to study individuals with ALS, demonstrating a link
between ALS progression and behavior and function patterns in people with amyotrophic lateral
sclerosis, as measured by digital wearables [9] [10] [11] [12]. These measurements include total activity
volume, active versus sedentary time, and time spent at home. Additionally, wearable devices are
increasingly utilized to investigate physical activity in populations with cardiovascular disease, multiple
sclerosis, arthritis, and other conditions. Although studies have been conducted to predict characteristics
related to the ALSFRS score, such as its score and slope, to date, there are no predictors leveraging data
from smartwatches to predict the ALSFRS score [13] [
        <xref ref-type="bibr" rid="ref8">8</xref>
        ]. Hence, it is imperative to investigate such
data types extensively to ascertain if they can enhance diagnostic predictions.
      </p>
    </sec>
    <sec id="sec-3">
      <title>3. Methodology</title>
      <p>Three diferent types of data were used to predict ALSFRS-R scores: sensor data from Garmin VivoActive
4 smartwatches, static feature data, and ALSFRS-R questionnaire data. Regarding sensor data, these
consist of 90 diferent features per day and are characterized by a large number of missing values (in
many days, no features were recorded, rendering the sensor vector absent for those days) due to both
the data collection device and patient behavior. The static data are baseline characteristics recorded at a
specific time, they include: sex, diagnostic delay, age at diagnosis, forced vital capacity (FVC), weight,
and body mass index (BMI). Finally, the ALSFRS-R data are of the same type as those to be predicted
but collected at a previous time.</p>
      <p>To leverage these challenging data, two diferent approaches have been explored: the Mono Window
approach and the Double Window approach. The Mono Window approach is the simpler of the two:
for each prediction, only the sensors recorded within 7 days prior to the questionnaire to be predicted
are used (these can be utilized in various ways, such as averaging or taking the median). The second
approach involves considering two sensor data windows instead of one: the first window adjacent
to the questionnaire to be predicted, and the second adjacent to the previous available questionnaire.
The idea behind this second method is to provide the model with more information about the changes
Frequencies of Residues Values in the Training ALSFRS-R Data
0
.3
0
.2
0
le .-1
u
a
V .0
0
0
.
1
0
.
3</p>
      <p>Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12</p>
      <p>Score name
in recorded parameters over time. Despite the large amount of sensor data (13.946 feature vectors)
and the fact that the second method seems more natural for handling this type of data, it is heavily
penalized by the irregularity of the sensors. Indeed, two 7-day windows with at least 3 days of sensor
data were not available in 20 out of 54 patients. For this reason, the choice to use the first approach
was mandatory. In this process, for each patient, all sensor data outside the temporal window of the 7
days preceding the ALSFRS-R values to be predicted was disregarded. The sensor data within each time
window were averaged along the time to obtain one feature vector of length 90 for each window that is
less afected by daily variability. Once the feature vectors representing the sensor data were obtained,
they were concatenated with the vectors of static features and with the vectors of previous ALSFRS-R
data before the questionnaires to be predicted; by doing this the the final feature vectors were obtained.</p>
      <p>Regarding the outcomes to predict, these are the values of ALSFRS-R questionnaires after the last
ones available for the training. To solve this task, it has been observed that the questionnaire values
tend to remain constant between visits (see Figure 1); therefore, it was decided to use the previous
time’s questionnaire score as the prediction baseline and to fit the model on the residuals. To obtain
the final prediction value, it was suficient to add the predicted residual to the value of the previous
questionnaire relative to the one to be predicted1. The Random Forest Classifier was chosen as the
model; unlike deep learning models, it does not require large datasets for training, making it suitable
for this task. Before being used to fit the model, the data were preprocessed by scaling and performing
feature selection, as explained in the section 4.</p>
    </sec>
    <sec id="sec-4">
      <title>4. Experimental Setup</title>
      <p>The training dataset for this challenge comprises data from 52 diferent patients for both tasks. These
data can be categorized into three types: static data, ALSFRS-R data, and data from a smartwatch sensor.
By analyzing the correlation matrices, two important facts can be observed: as for the ALSFRS-R data, it
can be observed that they can be divided into several correlated groups depending on the area afected by
the disease (see Figure 2). Meanwhile, regarding the sensor data, there are strongly correlated features,
as shown in the figure 3. As shown in the image, the correlated features are grouped into distinct blocks.
For the cardiac features, two main blocks can be identified: the first, smaller block pertains to Heart Rate
Variability (HRV), while the second block encompasses other cardiac characteristics related to the RR
interval. For the respiratory features, two blocks are associated with respiration and blood oxygenation.
Lastly, another block of correlated features pertains to the patient’s steps. The grouping of features
1The samples in the training set corresponding to a residual value occurring fewer than 8 times have been discarded; indeed,
they are too few to be recognized by the model.
(a) Task 1
(b) Task 2
into these blocks is expected, as they represent diferent statistics describing the same physiological
processes.</p>
      <p>The two tasks difer only in terms of the subject and the frequency with which the questionnaires
are filled out. This makes the two tasks slightly diferent primarily for two reasons: the data from the
ifrst task should reasonably be more objective, as it is a clinician who fills out the questionnaires rather
than the individual patient. Additionally, the data from the second task are compiled through an app
and have therefore a higher and more irregular frequency, as depicted in Figure 4.</p>
      <p>Regarding data preprocessing, the features were initially scaled using Min-Max Scaler and imputed
with the mean or mode depending on their continuous or categorical nature. Concerning the sensor data,
an additional process was added: the correlation between each of these features and the questionnaire
to be predicted was calculated, and only those features with a correlation above a certain threshold
were retained. This approach was chosen due to the low number of samples available to train the
model compared to the total number of features. After the data preprocessing, they were used to train a
Random Forest Classifier. To determine the optimal hyperparameters of the model 2, along with the
correlation threshold utilized to select the sensor features3, the following cross-validation strategy was
employed. The training set of the challenge was divided into an inner training set and a validation set
(80-20%). Hyperparameter optimization was conducted via cross-validation on the inner training set
using a grid search method4, and the chosen hyperparameters for each the tasks are displayed in Table
1 and Table 2.</p>
    </sec>
    <sec id="sec-5">
      <title>5. Results</title>
      <p>
        The challenge was divided into two tasks, Task 1 and Task 2, each involving the construction of a
model to predict the values of ALSFRS-R questionnaires completed by either a clinician or the patient
using a dedicated smartphone application. Despite testing two diferent macro types of methods: Mono
Window and Double Window, the low number of patients in the training set resulted in significantly
lower performance for the second type. Therefore, we only submitted results from the first type. These
2The Random Forest hyperparameters tested were maxing deep and max features; they have been tested respectively in ranges
[
        <xref ref-type="bibr" rid="ref2">2, 9</xref>
        ] and [sqrt, ’log2’, None]. The number of trees was fixed at 300.
3The thresholds tested has been [0, 0.05, 0.1, 0.15, 0.2, 0.25].
4During the fold creation process, care was taken to obtain stratified folds for outcomes to ensure partitions with similar
percentages for each outcome category.
      </p>
      <p>Sensors correlation matrix in the Training set</p>
    </sec>
    <sec id="sec-6">
      <title>6. Conclusions and Future Work</title>
      <p>The models attempted to predict the ALSFRS-R questionnaire values were constrained by the small
size of the training dataset. Despite experimenting with models utilizing various time intervals, the
only ones proving useful for prediction were those solely relying on a window of sensor data adjacent
to the questionnaire to be predicted, without leveraging information from more distant times. This
limitation stems from the challenging nature of the data, which contains a large number of missing
values. Among the models tested, the one demonstrating the best performance and subsequently used
for submission was based on Random Forest, preceded by a feature selection step to reduce the number
of sensor features.
(a) Task 1
50
100
200
250
300
0
50</p>
      <p>The performance obtained shows significant variability depending on the questionnaire number;
The Mean Absolute Error (MAE) calculated on the test set is 0.23 and 0.31 respectively for Task 1 and
Task 2, while the Root Mean Squared Error (RMSE) is 0.52 and 0.60 respectively. The lower error is
observed in the first task, which could be attributed to the fact that the questionnaire compilation
by clinical staf tends to be more reliable and objective compared to the subjective opinion from the
patient. These seemingly promising results are unfortunately attributed to the ALSFRS-R questionnaires
mostly remaining constant from one visit to another, making it very easy to achieve high prediction
performance.</p>
      <p>To address this issue, one potential approach to improve is using data augmentation to increase the
number of questionnaires in the training set. To improve predictions, methods of deep learning could be
tested, leveraging much longer sequences of sensor data (such as recurrent neural networks). However,
these models require significantly more data for training, which represent the biggest obstacle for this
task.
MAE (std)
learning methods to predict amyotrophic lateral sclerosis disease progression, Scientific reports
12 (2022) 13738.
[9] M. Straczkiewicz, M. Karas, S. A. Johnson, K. M. Burke, Z. Scheier, T. B. Royse, N. Calcagno,
A. Clark, A. Iyer, J. D. Berry, et al., Upper limb movements as digital biomarkers in people with
als, EBioMedicine 101 (2024).
[10] L. Garcia-Gancedo, M. L. Kelly, A. Lavrov, J. Parr, R. Hart, R. Marsden, M. R. Turner, K. Talbot,
T. Chiwera, C. E. Shaw, et al., Objectively monitoring amyotrophic lateral sclerosis patient
symptoms during clinical trials with sensors: observational study, JMIR mHealth and uHealth 7
(2019) e13433.
[11] V. Ezeugwu, R. E. Klaren, E. A. Hubbard, P. T. Manns, R. W. Motl, Mobility disability and the
pattern of accelerometer-derived sedentary and physical activity behaviors in people with multiple
sclerosis, Preventive medicine reports 2 (2015) 241–246.
[12] R. P. van Eijk, J. N. Bakers, T. M. Bunte, A. J. de Fockert, M. J. Eijkemans, L. H. van den Berg,
Accelerometry for remote monitoring of physical activity in amyotrophic lateral sclerosis: a
longitudinal cohort study, Journal of neurology 266 (2019) 2387–2395.
[13] A. G. Karanevich, J. M. Statland, B. J. Gajewski, J. He, Using an onset-anchored bayesian hierarchical
model to improve predictions for amyotrophic lateral sclerosis disease progression, BMC medical
research methodology 18 (2018) 1–13.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <mixed-citation>
          [1]
          <string-name>
            <given-names>L. C.</given-names>
            <surname>Wijesekera</surname>
          </string-name>
          ,
          <string-name>
            <given-names>P.</given-names>
            <surname>Nigel</surname>
          </string-name>
          <string-name>
            <surname>Leigh</surname>
          </string-name>
          , Amyotrophic lateral sclerosis,
          <source>Orphanet journal of rare diseases 4</source>
          (
          <year>2009</year>
          )
          <fpage>1</fpage>
          -
          <lpage>22</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref2">
        <mixed-citation>
          [2]
          <string-name>
            <given-names>E. O.</given-names>
            <surname>Talbott</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A. M.</given-names>
            <surname>Malek</surname>
          </string-name>
          ,
          <string-name>
            <given-names>D.</given-names>
            <surname>Lacomis</surname>
          </string-name>
          ,
          <article-title>The epidemiology of amyotrophic lateral sclerosis</article-title>
          ,
          <source>Handbook of clinical neurology 138</source>
          (
          <year>2016</year>
          )
          <fpage>225</fpage>
          -
          <lpage>238</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref3">
        <mixed-citation>
          [3]
          <string-name>
            <given-names>J. M.</given-names>
            <surname>Cedarbaum</surname>
          </string-name>
          ,
          <string-name>
            <given-names>N.</given-names>
            <surname>Stambler</surname>
          </string-name>
          ,
          <string-name>
            <given-names>E.</given-names>
            <surname>Malta</surname>
          </string-name>
          ,
          <string-name>
            <given-names>C.</given-names>
            <surname>Fuller</surname>
          </string-name>
          ,
          <string-name>
            <given-names>D.</given-names>
            <surname>Hilt</surname>
          </string-name>
          ,
          <string-name>
            <given-names>B.</given-names>
            <surname>Thurmond</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            <surname>Nakanishi</surname>
          </string-name>
          ,
          <string-name>
            <given-names>B. A. S.</given-names>
            <surname>Group</surname>
          </string-name>
          ,
          <string-name>
            <surname>A.</surname>
          </string-name>
          <article-title>complete listing of the BDNF Study Group</article-title>
          , et al.,
          <article-title>The alsfrs-r: a revised als functional rating scale that incorporates assessments of respiratory function</article-title>
          ,
          <source>Journal of the neurological sciences 169</source>
          (
          <year>1999</year>
          )
          <fpage>13</fpage>
          -
          <lpage>21</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref4">
        <mixed-citation>
          [4]
          <string-name>
            <given-names>G.</given-names>
            <surname>Birolo</surname>
          </string-name>
          ,
          <string-name>
            <given-names>P.</given-names>
            <surname>Bosoni</surname>
          </string-name>
          , G. Faggioli,
          <string-name>
            <given-names>H.</given-names>
            <surname>Aidos</surname>
          </string-name>
          ,
          <string-name>
            <given-names>R.</given-names>
            <surname>Bergamaschi</surname>
          </string-name>
          ,
          <string-name>
            <given-names>P.</given-names>
            <surname>Cavalla</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            <surname>Chiò</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            <surname>Dagliati</surname>
          </string-name>
          , M. de Carvalho,
          <string-name>
            <given-names>G. M.</given-names>
            <surname>Di Nunzio</surname>
          </string-name>
          ,
          <string-name>
            <given-names>P.</given-names>
            <surname>Fariselli</surname>
          </string-name>
          ,
          <string-name>
            <given-names>J. M.</given-names>
            <surname>García Dominguez</surname>
          </string-name>
          ,
          <string-name>
            <given-names>M.</given-names>
            <surname>Gromicho</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            <surname>Guazzo</surname>
          </string-name>
          ,
          <string-name>
            <given-names>E.</given-names>
            <surname>Longato</surname>
          </string-name>
          ,
          <string-name>
            <given-names>S. C.</given-names>
            <surname>Madeira</surname>
          </string-name>
          ,
          <string-name>
            <given-names>U.</given-names>
            <surname>Manera</surname>
          </string-name>
          ,
          <string-name>
            <given-names>S.</given-names>
            <surname>Marchesin</surname>
          </string-name>
          ,
          <string-name>
            <given-names>L.</given-names>
            <surname>Menotti</surname>
          </string-name>
          ,
          <string-name>
            <given-names>G.</given-names>
            <surname>Silvello</surname>
          </string-name>
          ,
          <string-name>
            <given-names>E.</given-names>
            <surname>Tavazzi</surname>
          </string-name>
          ,
          <string-name>
            <given-names>E.</given-names>
            <surname>Tavazzi</surname>
          </string-name>
          , I. Trescato,
          <string-name>
            <given-names>M.</given-names>
            <surname>Vettoretti</surname>
          </string-name>
          ,
          <string-name>
            <given-names>B. Di</given-names>
            <surname>Camillo</surname>
          </string-name>
          ,
          <string-name>
            <given-names>N.</given-names>
            <surname>Ferro</surname>
          </string-name>
          , Overview of idpp@clef
          <year>2024</year>
          :
          <article-title>The intelligent disease progression prediction challenge</article-title>
          ,
          <source>in: Working Notes of the Conference and Labs of the Evaluation Forum (CLEF</source>
          <year>2024</year>
          ), Grenoble, France,
          <source>September 9th to 12th</source>
          ,
          <year>2024</year>
          , CEUR Workshop Proceedings, CEUR-WS.org,
          <year>2024</year>
          .
        </mixed-citation>
      </ref>
      <ref id="ref5">
        <mixed-citation>
          [5]
          <string-name>
            <given-names>G.</given-names>
            <surname>Birolo</surname>
          </string-name>
          ,
          <string-name>
            <given-names>P.</given-names>
            <surname>Bosoni</surname>
          </string-name>
          , G. Faggioli,
          <string-name>
            <given-names>H.</given-names>
            <surname>Aidos</surname>
          </string-name>
          ,
          <string-name>
            <given-names>R.</given-names>
            <surname>Bergamaschi</surname>
          </string-name>
          ,
          <string-name>
            <given-names>P.</given-names>
            <surname>Cavalla</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            <surname>Chiò</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            <surname>Dagliati</surname>
          </string-name>
          , M. de Carvalho,
          <string-name>
            <given-names>G. M.</given-names>
            <surname>Di Nunzio</surname>
          </string-name>
          ,
          <string-name>
            <given-names>P.</given-names>
            <surname>Fariselli</surname>
          </string-name>
          ,
          <string-name>
            <given-names>J. M.</given-names>
            <surname>García Dominguez</surname>
          </string-name>
          ,
          <string-name>
            <given-names>M.</given-names>
            <surname>Gromicho</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            <surname>Guazzo</surname>
          </string-name>
          ,
          <string-name>
            <given-names>E.</given-names>
            <surname>Longato</surname>
          </string-name>
          ,
          <string-name>
            <given-names>S. C.</given-names>
            <surname>Madeira</surname>
          </string-name>
          ,
          <string-name>
            <given-names>U.</given-names>
            <surname>Manera</surname>
          </string-name>
          ,
          <string-name>
            <given-names>S.</given-names>
            <surname>Marchesin</surname>
          </string-name>
          ,
          <string-name>
            <given-names>L.</given-names>
            <surname>Menotti</surname>
          </string-name>
          ,
          <string-name>
            <given-names>G.</given-names>
            <surname>Silvello</surname>
          </string-name>
          ,
          <string-name>
            <given-names>E.</given-names>
            <surname>Tavazzi</surname>
          </string-name>
          ,
          <string-name>
            <given-names>E.</given-names>
            <surname>Tavazzi</surname>
          </string-name>
          , I. Trescato,
          <string-name>
            <given-names>M.</given-names>
            <surname>Vettoretti</surname>
          </string-name>
          ,
          <string-name>
            <given-names>B. Di</given-names>
            <surname>Camillo</surname>
          </string-name>
          ,
          <string-name>
            <given-names>N.</given-names>
            <surname>Ferro</surname>
          </string-name>
          ,
          <article-title>Intelligent disease progression prediction: Overview of idpp@clef 2024, in: Experimental IR Meets Multilinguality</article-title>
          , Multimodality, and Interaction - 15th
          <source>International Conference of the CLEF Association, CLEF</source>
          <year>2024</year>
          , Grenoble, France,
          <source>September 9th to 12th</source>
          ,
          <year>2024</year>
          , Lecture Notes in Computer Science, Springer,
          <year>2024</year>
          .
        </mixed-citation>
      </ref>
      <ref id="ref6">
        <mixed-citation>
          [6]
          <string-name>
            <given-names>R.</given-names>
            <surname>Kuefner</surname>
          </string-name>
          ,
          <string-name>
            <given-names>N.</given-names>
            <surname>Zach</surname>
          </string-name>
          ,
          <string-name>
            <given-names>M.</given-names>
            <surname>Bronfeld</surname>
          </string-name>
          ,
          <string-name>
            <given-names>R.</given-names>
            <surname>Norel</surname>
          </string-name>
          ,
          <string-name>
            <given-names>N.</given-names>
            <surname>Atassi</surname>
          </string-name>
          ,
          <string-name>
            <given-names>V.</given-names>
            <surname>Balagurusamy</surname>
          </string-name>
          ,
          <string-name>
            <given-names>B. Di</given-names>
            <surname>Camillo</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            <surname>Chio</surname>
          </string-name>
          ,
          <string-name>
            <given-names>M.</given-names>
            <surname>Cudkowicz</surname>
          </string-name>
          ,
          <string-name>
            <given-names>D.</given-names>
            <surname>Dillenberger</surname>
          </string-name>
          , et al.,
          <article-title>Stratification of amyotrophic lateral sclerosis patients: a crowdsourcing approach</article-title>
          ,
          <source>Scientific reports 9</source>
          (
          <year>2019</year>
          )
          <fpage>690</fpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref7">
        <mixed-citation>
          [7]
          <string-name>
            <given-names>M.</given-names>
            <surname>Tang</surname>
          </string-name>
          ,
          <string-name>
            <given-names>C.</given-names>
            <surname>Gao</surname>
          </string-name>
          ,
          <string-name>
            <given-names>S. A.</given-names>
            <surname>Goutman</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            <surname>Kalinin</surname>
          </string-name>
          ,
          <string-name>
            <given-names>B.</given-names>
            <surname>Mukherjee</surname>
          </string-name>
          ,
          <string-name>
            <given-names>Y.</given-names>
            <surname>Guan</surname>
          </string-name>
          ,
          <string-name>
            <given-names>I. D.</given-names>
            <surname>Dinov</surname>
          </string-name>
          ,
          <article-title>Model-based and model-free techniques for amyotrophic lateral sclerosis diagnostic prediction and patient clustering</article-title>
          ,
          <source>Neuroinformatics</source>
          <volume>17</volume>
          (
          <year>2019</year>
          )
          <fpage>407</fpage>
          -
          <lpage>421</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref8">
        <mixed-citation>
          [8]
          <string-name>
            <given-names>C.</given-names>
            <surname>Pancotti</surname>
          </string-name>
          , G. Birolo,
          <string-name>
            <given-names>C.</given-names>
            <surname>Rollo</surname>
          </string-name>
          ,
          <string-name>
            <given-names>T.</given-names>
            <surname>Sanavia</surname>
          </string-name>
          ,
          <string-name>
            <given-names>B. Di</given-names>
            <surname>Camillo</surname>
          </string-name>
          ,
          <string-name>
            <given-names>U.</given-names>
            <surname>Manera</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            <surname>Chiò</surname>
          </string-name>
          ,
          <string-name>
            <given-names>P.</given-names>
            <surname>Fariselli</surname>
          </string-name>
          , Deep
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>